Funder: American Heart Association
Due Dates: January 6, 2026 (Pre-proposal, required) | April 14, 2026 (Invited full proposal)
Funding Amounts: $100,000 per award (1 year, including up to 10% indirect costs); up to 10 awards anticipated.
Summary: Supports innovative translational research and novel solutions addressing critical gaps in women's cardiovascular, autoimmune, and reproductive health with commercialization potential.
Key Information: Pre-proposal required; U.S.-based nonprofit institutions only; AHA Professional Membership required at submission.